Immunome Inc. (IMNM)
NASDAQ · Healthcare
Immunome Inc. Shareholder Equity 2023–2025
Immunome Inc. annual/quarterly shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Immunome Inc. shareholder equity for the quarter ending December 31, 2025 were 634.3M, a 250.15% increase year-over-year.
- Immunome Inc. shareholder equity for 2025 were 634.3M, a 250.15% increase from 2024.
- Immunome Inc. shareholder equity for 2024 were 181.2M, a 51.12% increase from 2023.
- Immunome Inc. shareholder equity for 2023 were 119.9M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Immunome Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $634 |
| 2024 | $181 |
| 2023 | $120 |
| Immunome Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $634 |
| 2024-12-31 | $181 |
| 2023-12-31 | $120 |
Immunome Inc. Shareholder Equity — FAQ
Immunome Inc. (IMNM) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMNM's shareholder equity history?
The chart and table above show Immunome Inc.'s shareholder equity by year and by quarter, including the growth rate.